Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$31,660,212
+$9,883,899 QoQ
Shares Held
1,230,957
+8.5% QoQ
Ownership
0.770%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 290 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. DNLI ranks #66 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in DNLI
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,660,212 | 1,230,957 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $21,776,313 | 1,134,183 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $15,389,694 | 932,144 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $13,955,721 | 961,138 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $9,096,603 | 650,222 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,087,254 | 447,757 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,509,384 | 270,333 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,142,014 | 348,164 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $17,230,352 | 742,048 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $17,482,546 | 851,976 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,842,370 | 458,638 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,102,228 | 295,794 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,974,927 | 270,245 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,673,019 | 419,836 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $9,310,006 | 334,772 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $6,758,456 | 220,217 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,504,139 | 119,067 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,760,526 | 241,235 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,751,080 | 128,948 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $3,927,329 | 77,846 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $2,956,122 | 51,771 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $3,961,343 | 47,294 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,042,759 | 29,103 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $807,852 | 33,410 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $483,433 | 27,609 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||